[accordion]
[acc title=”IMI2-2016-10-01: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials“]
Status: Open
Publication date: 21 December 2016
Types of action: IMI2-RIA Research and Innovation action
DeadlineModel: two-stage
Opening date: 04 January 2017
Deadline: 28 March 2017 17:00:00 (Brussels time)
2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)
[/acc]
[acc title=”IMI2-2016-10-02: How Big Data could support better diagnosis and treatment outcomes for Prostate Cancer“]
Status: Open
Publication date: 21 December 2016
Types of action: IMI2-RIA Research and Innovation action
DeadlineModel: two-stage
Opening date: 04 January 2017
Deadline: 28 March 2017 17:00:00 (Brussels time)
2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)
[/acc]
[acc title=”IMI2-2016-10-03: Improving the care of patients suffering from acute or chronic pain“]
Status: Open
Publication date: 21 December 2016
Types of action: IMI2-RIA Research and Innovation action
DeadlineModel: two-stage
Opening date: 04 January 2017
Deadline: 28 March 2017 17:00:00 (Brussels time)
[/acc]
[acc title=”IMI2-2016-10-04: Creation of a pan-European Paediatric Clinical Trials Network“]
Status: Open
Publication date: 21 December 2016
Types of action: IMI2-RIA Research and Innovation action
DeadlineModel: two-stage
Opening date: 04 January 2017
Deadline: 28 March 2017 17:00:00 (Brussels time)
2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)
[/acc]
[acc title=”IMI2-2016-10-05: Biomanufacturing 2020: Development of Innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes“]
Status: Open
Publication date: 21 December 2016
Types of action: IMI2-RIA Research and Innovation action
DeadlineModel: two-stage
Opening date: 04 January 2017
Deadline: 28 March 2017 17:00:00 (Brussels time)
2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)
[/acc]
[acc title=”IMI2-2016-10-06: Unlocking the Solute Carrier Gene-Family for Effective New Therapies (Unlock SLCs)“]
Status: Open
Publication date: 21 December 2016
Types of action: IMI2-RIA Research and Innovation action
DeadlineModel: two-stage
Opening date: 04 January 2017
Deadline: 28 March 2017 17:00:00 (Brussels time)
2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)
[/acc]
[acc title=”IMI2-2016-10-07: Patient perspectives in medicines lifecycle“]
Status: Open
Publication date: 21 December 2016
Types of action: IMI2-RIA Research and Innovation action
DeadlineModel: two-stage
Opening date: 04 January 2017
Deadline: 28 March 2017 17:00:00 (Brussels time)
2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)
[/acc]
[acc title=”IMI2-2016-10-08: Personalised medicine approaches in autism spectrum disorders“]
Status: Open
Publication date: 21 December 2016
Types of action: IMI2-RIA Research and Innovation action
DeadlineModel: two-stage
Opening date: 04 January 2017
Deadline: 28 March 2017 17:00:00 (Brussels time)
2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)
[/acc]
[/accordion]
